2,4-Cyclopentadien-1-one, 2,5-bis(4-bromophenyl)-3,4-diphenyl-
CAS54523-24-9
2,4-Cyclopentadien-1-one, 2,5-bis(4-bromophenyl)-3,4-diphenyl- (CAS 54523-24-9, C29H18Br2O) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 54523-24-9
- Formula
- C29H18Br2O
- Mol. weight
- 542.26 g/mol
Chemical Specifications
Identifiers
| CAS number | 54523-24-9 |
|---|---|
| Product name | 2,4-Cyclopentadien-1-one, 2,5-bis(4-bromophenyl)-3,4-diphenyl- |
| Molecular formula | C29H18Br2O |
| Molecular weight | 542.26 g/mol |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of 2,4-Cyclopentadien-1-one, 2,5-bis(4-bromophenyl)-3,4-diphenyl-?
The CAS Registry Number of 2,4-Cyclopentadien-1-one, 2,5-bis(4-bromophenyl)-3,4-diphenyl- is 54523-24-9.
What is the molecular formula and molecular weight of 2,4-Cyclopentadien-1-one, 2,5-bis(4-bromophenyl)-3,4-diphenyl-?
The molecular formula of 2,4-Cyclopentadien-1-one, 2,5-bis(4-bromophenyl)-3,4-diphenyl- is C29H18Br2O, and its molecular weight is 542.26 g/mol.
How can I request a quotation for 2,4-Cyclopentadien-1-one, 2,5-bis(4-bromophenyl)-3,4-diphenyl-?
Send an inquiry for 2,4-Cyclopentadien-1-one, 2,5-bis(4-bromophenyl)-3,4-diphenyl- (CAS 54523-24-9) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for 2,4-Cyclopentadien-1-one, 2,5-bis(4-bromophenyl)-3,4-diphenyl-
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.